Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2018-09-21

New gene therapy for rare inherited disorder causing vision loss recommended for approval

View source ↗

Summary

The EMA recommends approval of a new gene therapy intended to treat a rare inherited disorder that causes vision loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications